News
Disposable Contact Lenses Market Witnesses Surge Among Millennials Seeking Comfort and Style Options
The global disposable contact lenses market has experienced robust growth in recent years, driven by evolving consumer ...
The single-use syringe market is experiencing significant momentum globally due to a surge in healthcare demand, rising ...
The global breathing circuit market is undergoing a pivotal transformation, shaped by technological innovation, rising ...
The laparoscopic devices market is at the forefront of surgical transformation, driven by an increasing demand for minimally ...
POTOMAC, MD / ACCESS Newswire / July 21, 2025 / IGC Pharma, Inc. (NYSE American:IGC) a clinical-stage biopharmaceutical company focused on Alzheimer's disease, today announced that its Principal ...
OAKLAND PARK, FL / ACCESS Newswire / July 21, 2025 / EndoUVTech is a medical device innovator specializing in UV laser-based surgical technologies for blood clots in the brain, today announced that ...
MESA, ARIZONA / ACCESS Newswire / July 21, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) is pleased to announce that its wholly owned subsidiary, Infinite Auctions, has completed the sale of a ...
A state‑of‑the‑art, 100,000+ square‑foot facility in Largo, Florida, will serve as the company's new operational hub. LARGO, FL / ACCESS Newswire / July 21, 2025 / SMP Nutra, a leading contract ...
Her Royal Highness The Princess Royal Officially Opens Insmed’s New Research and Development Facility in Cambridge, UK LONDON, Friday 18 July 2025, Insmed Incorporated (Nasdaq: INSM), a people-first ...
NuCana Cancels All Outstanding Series A Warrants Following Strategic ATM ExecutionEDINBURGH, United Kingdom, July 21, 2025 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) (“NuCana” or the “Company”) ...
Tiziana Life Sciences Announces Immunologic Analysis of Nasal Foralumab in Moderate Alzheimer's PatientNEW YORK, July 21, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” ...
OncoZenge Appoints Meribel Pharma as CDMO for BupiZenge™ Phase 3 ProjectOncoZenge AB ("OncoZenge" or "the Company") today announced it has engaged Meribel Pharma Solutions ("Meribel," formerly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results